Skip to main content

Advertisement

Log in

Distribution, biosynthesis and therapeutic potential of lignans

  • Review Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

Lignans have long been known for their abundant therapeutic properties due to their polyphenolic structure. Linseed is the richest plant source of lignans and has been studied widely for their properties. The most prevalent lignan, secoisolariciresinol diglucoside (SDG), is consumed with linseed and converted into mammalian lignans, enterodiol (END) and enterolactone (ENL), by the gut microbiota. SDG can easily be assessed using HPLC and its deglycosylated form viz secoisolariciresinol can be asses using GC–MS techniques. Variety of extraction and analysis methods has been reported for plant lignans. SDG is known to have therapeutic properties including anti-oxidant, anti-cancerous, anti-inflammatory, modulation of gene expression, anti-diabetic, estrogenic and anti-estrogenic. Despite a large number of bioactivities, strong evidences for the underlying mechanisms for most of the properties are still unknown. SDG is most studied for its anti-cancerous properties. But the use of lignans as anti-carcinogenic agent is limited and commercially not reported due to challenges of purification at commercial level, rapid metabolism, untargeted delivery and toxic compounds associated with lignans. Exploration of more prominent and active derivatives of SDG and their targeted drug delivery should be an important research toward the use of bioactive lignans of linseed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Download references

Acknowledgements

Authors are grateful to Department of Biotechnology, Government of India for providing financial support under Project No. BT/Ag/Network/2019-2020/29.02.2020 awarded to Dr. Nutan Kaushik.

Funding

The financial support was provided by Department of Biotechnology, Government of India under Project No. BT/Ag/Network/2019–2020/29.02.2020 awarded to Dr. Nutan Kaushik.

Author information

Authors and Affiliations

Authors

Contributions

NK conceived the idea of manuscript. NSP, SA and AS wrote the manuscript. The figures were prepared by NSP. The review has been checked and finalized by NK.

Corresponding author

Correspondence to Nutan Kaushik.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest regarding the publication of this manuscript.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

We affirm that all the authors have seen, prepared, and agreed to the submission of paper and their inclusion of name(s) as co-author(s). We also declare that there are no conflicts of interests for the same.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Plaha, N.S., Awasthi, S., Sharma, A. et al. Distribution, biosynthesis and therapeutic potential of lignans. 3 Biotech 12, 255 (2022). https://doi.org/10.1007/s13205-022-03318-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-022-03318-9

Keywords

Navigation